About
Technology
Issues
FAQ
Links
Official Page
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.